Published 2 years ago

U.S. FDA clears additional lots of Moderna's Covid booster amid shortage

Summary by Ground News

The U.S. Food and Drug Administration said on Monday it has authorized an additional five batches of Moderna Inc's updated Covid booster shots made at a Catalent facility in Indiana. Last week, the health regulator had allowed use of ten batches. The FDA had earlier said Moderna had requested authorization for additional batches.

0 Articles

All

Left

Center

Right

Reuters

U.S. FDA clears additional lots of Moderna's Covid booster amid shortage

The U.S. Food and Drug Administration said on Monday it has authorized an additional five batches of Moderna Inc's updated Covid booster shots made at a Catalent facility in Indiana, after it deemed them safe for use. Last week, the health regulator had allowed use of ten batches of Moderna's updated booster shots made at the Bloomington, Indiana facility, owned by a unit of Catalent

2 years ago·United Kingdom

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.